- Chikungunya is a viral infection transmitted by infected mosquitoes common in some tropical regions including the Caribbean, which is in peak tourism season between December and April1
-
According to UKHSA, 2025 saw the highest number of travel-associated Chikungunya cases recorded in England, doubling from last year2
-
Boots adds the chikungunya vaccination to its Travel Vaccination Service that is available in over 270 Boots stores
Boots has added the chikungunya vaccination to its private Boots Travel Vaccination and Health Advice Service*, available in over 270 stores across the UK, ahead of the peak travel season to destinations where the viral infection is most prevalent.
Chikungunya is a viral mosquito-borne infection most commonly contracted in popular winter holiday destinations including Asia, Africa and Americas. Symptoms include a sudden onset of fever accompanied by joint and muscle pain. Many people also experience headaches, sensitivity to light and distinctive skin rashes. While most people recover fully within one to two weeks, for some joint pain can persist for months or even years.
Cases of the travel-associated chikungunya cases have more than doubled in the last year, according to data from the UK Health and Security Agency (UKHSA).3 Boots is encouraging British holiday makers seeking some summer sun to protect themselves from chikungunya by getting vaccinated before travelling.
Claire Nevinson, Superintendent Pharmacist at Boots, said: “The Chikungunya Vaccination Service gives travellers the option to minimise the risks of contracting and developing symptoms from the virus. It adds to the breadth of vaccinations we offer to protect holidaymakers against infectious diseases that we may not be exposed to in the UK such as yellow fever, cholera and typhoid. It’s so quick and easy to get advice, support and any vaccinations you need for your holidays on the high street. I encourage those who are travelling to exciting destinations across the world over the festive season to book an appointment with one of our expert pharmacists today.”
The Chikungunya vaccination service is available as part of the Boots Travel Vaccination and Health Advice Service, starting from £180 and suitable for those aged 12 and above. It is the latest addition to the health, wellness and beauty retailer’s expanding range of over 180 healthcare services, which are delivered in-store and online on behalf of the NHS as well as privately.
To help patients understand more about Chikungunya, Claire answers three key questions:
-
How is Chikungunya spread?
“Chikungunya spreads through the bite of infected mosquitoes. Mosquitoes breed in natural and human-made sources of standing and stagnant water such as blocked gutters and drains, bins and plant pots. Unlike malaria-carrying mosquitoes that are active at night, these insects are most active during the day, and particularly at dusk and dawn. This timing can put travellers who engage in daytime activities at risk.”
-
When could I be at risk of Chikungunya?
“If you are travelling overseas to tropical and sub-tropical places such as Kenya, Tanzania, India, Maldives, Caribbean and Pacific region, you may be at risk of the chikungunya virus. Serious complications are rare, however, certain groups face higher risks including young babies, elderly people and adults with underlying health conditions.”
-
How can I protect myself from Chikungunya?
“Currently, there is no specific antiviral treatment for chikungunya. The main way to prevent chikungunya is to avoid mosquito bites, including using repellents containing DEET on exposed skin and wearing light-coloured, loose-fitting clothing that covers arms and legs. Insect repellent should be applied after sunscreen and regularly reapplied after any activities, including swimming. The Chikungunya vaccination can also help protect against the disease for eligible travellers.”
*Eligibility criteria and charges apply. A consultation fee may apply. Available in selected pharmacies, subject to availability.
2,3 UKHSA, August 2025. A total of 73 cases were reported between January and June 2025. The same period in 2024 saw 27 cases.